SG Americas Securities
CGEM icon

SG Americas Securities’s Cullinan Oncology CGEM Stock Holding History

SG Americas Securities’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$347K Buy
19,058
+3,579
+23% +$53.1K ﹤0.01% 2512
2026
Q1 		$220K Sell
15,479
-152
-1% -$1.95K ﹤0.01% 2594
2025
Q4 		$162K Buy
15,631
+5,165
+49% +$46.6K ﹤0.01% 3018
2025
Q3 		$62K Buy
+10,466
New +$76.6K ﹤0.01% 3166
2025
Q2 		– Sell
-16,636
Closed -$126K – 3017
2025
Q1 		$126K Sell
16,636
-6,565
-28% -$63K ﹤0.01% 2876
2024
Q4 		$283K Buy
23,201
+8,144
+54% +$117K ﹤0.01% 1843
2024
Q3 		$252K Sell
15,057
-70,115
-82% -$1.24M ﹤0.01% 2294
2024
Q2 		$1.49M Buy
85,172
+75,236
+757% +$1.6M 0.01% 1113
2024
Q1 		$169K Sell
9,936
-4,513
-31% -$69.7K ﹤0.01% 2099
2023
Q4 		$147K Buy
14,449
+1,587
+12% +$14.1K ﹤0.01% 2433
2023
Q3 		$116K Buy
+12,862
New +$134K ﹤0.01% 2693
2023
Q2 		– Sell
-11,066
Closed -$113K – 2407
2023
Q1 		$113K Sell
11,066
-1,071
-9% -$11.8K ﹤0.01% 2831
2022
Q4 		$128K Buy
12,137
+949
+8% +$11.5K ﹤0.01% 2543
2022
Q3 		$143K Sell
11,188
-1,420
-11% -$19.1K ﹤0.01% 2580
2022
Q2 		$162K Buy
+12,608
New +$143K ﹤0.01% 2812
2022
Q1 		– Sell
-10,916
Closed -$168K – 3018
2021
Q4 		$168K Sell
10,916
-4,947
-31% -$98.7K ﹤0.01% 2758
2021
Q3 		$358K Buy
+15,863
New +$424K ﹤0.01% 2787

Other funds holding CGEM

MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

SG Americas Securities's CGEM Position: Q2 2026 in Review

SG Americas Securities increased its Cullinan Oncology (CGEM) stake by 23% in Q2 2026, buying an estimated $53.1K and bringing the position to 19,058 shares worth $347K. The position accounts for ﹤0.01% of the portfolio, ranked #2512.

SG Americas Securities first reported a position in CGEM in Q3 2021 and has held it in 17 quarters since. The position peaked at $1.49M in Q2 2024. 183 funds tracked by Wall St. Rank hold CGEM as of Q2 2026.

  • SG Americas Securities held 19,058 shares of Cullinan Oncology worth $347K as of Q2 2026.
  • SG Americas Securities bought 3,579 Cullinan Oncology shares in Q2 2026, an estimated $53.1K.
  • Cullinan Oncology made up ﹤0.01% of SG Americas Securities's portfolio in Q2 2026, its #2512 holding.
  • SG Americas Securities first reported a position in Cullinan Oncology in Q3 2021 and has held it in 17 quarters since.
  • SG Americas Securities's Cullinan Oncology position peaked at $1.49M in Q2 2024.
  • 183 funds tracked by Wall St. Rank held Cullinan Oncology as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.